BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33595705)

  • 41. Lymphocyte-to-Monocyte Ratio Is a Predictor of Survival After Liver Transplantation for Hepatocellular Carcinoma.
    Mano Y; Yoshizumi T; Yugawa K; Ohira M; Motomura T; Toshima T; Itoh S; Harada N; Ikegami T; Soejima Y; Maehara Y
    Liver Transpl; 2018 Nov; 24(11):1603-1611. PubMed ID: 29893464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum Insulin-Like Growth Factor-1 (IGF-1): a Novel Prognostic Factor for Early Recurrence of Hepatocellular Carcinoma (HCC).
    Yao Y; Mao W; Dong M; Yang D; Li W; Chen Y
    Clin Lab; 2017 Feb; 63(2):261-270. PubMed ID: 28182337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Zhang J; Luo Y; Li C; Liu J; Xiang H; Wen T
    Biosci Trends; 2019; 13(4):351-357. PubMed ID: 31527331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma.
    Lee DH; Lee JM; Yi NJ; Lee KW; Suh KS; Lee JH; Lee KB; Han JK
    Eur Radiol; 2017 Apr; 27(4):1713-1721. PubMed ID: 27456966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of modified systemic inflammatory score in patients with newly diagnosed high-grade gliomas.
    Xie T; Guo X; Duan H; He Z; Mou Y
    Clin Neurol Neurosurg; 2021 Feb; 201():106428. PubMed ID: 33383467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection.
    Yang T; Zhu J; Zhao L; Mai K; Ye J; Huang S; Zhao Y
    J Surg Oncol; 2017 May; 115(6):718-728. PubMed ID: 28127774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of preoperative inflammation-based score for the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy.
    Matsumoto T; Kitano Y; Imai K; Kinoshita S; Sato H; Shiraishi Y; Mima K; Hayashi H; Yamashita YI; Baba H
    Surg Today; 2022 Jul; 52(7):1008-1015. PubMed ID: 35083547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
    Luo H; Li C; Chen L
    Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival.
    Peng W; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2014 Dec; 192(2):402-8. PubMed ID: 24998425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
    Qin L; Li C; Xie F; Wang Z; Wen T
    Biosci Trends; 2020 Sep; 14(4):297-303. PubMed ID: 32641640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic inflammation score is a prognostic marker after curative resection in gastric cancer.
    Ma M; Weng M; Chen F; Hu Y; Lai J; Wang Y; Zhou Y
    ANZ J Surg; 2019 Apr; 89(4):377-382. PubMed ID: 30854753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
    Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
    Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic Inflammatory Score predicts Overall Survival in patients with Cervical Cancer.
    Xu M; Wu Q; Cai L; Sun X; Xie X; Sun P
    J Cancer; 2021; 12(12):3671-3677. PubMed ID: 33995642
    [No Abstract]   [Full Text] [Related]  

  • 56. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.
    Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L
    BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study.
    Kong W; Xu H; Cheng J; Fang Z; Wang H; Zhang J; Wang X; Dai T; Gao Y
    Med Sci Monit; 2020 Jan; 26():e918824. PubMed ID: 31929496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modified Child-Pugh grade
    Huang F; Gao J
    World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection.
    Yang YT; Jiang JH; Yang HJ; Wu ZJ; Xiao ZM; Xiang BD
    Sci Rep; 2018 Feb; 8(1):2535. PubMed ID: 29416061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Huge hepatocellular carcinoma greater than 10 cm in diameter worsens prognosis by causing distant recurrence after curative resection.
    Wakayama K; Kamiyama T; Yokoo H; Orimo T; Shimada S; Einama T; Kamachi H; Taketomi A
    J Surg Oncol; 2017 Mar; 115(3):324-329. PubMed ID: 28192617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.